EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity-Reference-Cited by-同舟云学术

EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity

Published:2016-01 Issue: Volume:52 Page:66-74
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Chang Jae Won,Gwak Seo Young,Shim Geun-Ae,Liu Lihua,Lim Young Chang,Kim Jin Man,Jung Min Gyu,Koo Bon Seok

Funder

National Research Foundation of Korea

National R and D Program for Cancer Control, Ministry for Health, Welfare, and Family Affairs, Republic of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference35 articles.

1. Epidemiologic trends in head and neck cancer and aids in diagnosis;Vigneswaran;Oral Maxillofac Surg Clin North Am,2014

2. Snail and slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma;Zheng;Oncotarget,2015

3. Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation;Howard;Oral Oncol,2012

4. Role of EZH2 in oral squamous cell carcinoma carcinogenesis;Zhao;Gene,2014

5. The Polycomb group protein EZH2 directly controls DNA methylation;Vire;Nature,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EZH2 Expression in Head-and-Neck Squamous Cell Cancer in Young Patients;International Journal of Molecular Sciences;2024-05-11

2. Basal differentiation and expression status of SOX2 and KLF4 in basal layers are prognostic factors for disease‐specific survival in oral squamous cell carcinoma;Journal of Oral Pathology & Medicine;2024-04-24

3. PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis;BMC Cancer;2024-04-22

4. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma;Clinical Epigenetics;2024-04-10

5. EZH2-mediated development of therapeutic resistance in cancer;Cancer Letters;2024-04